Effect of COVID-19 on cardiorenal axis: known or unknown universe?

G M Armentano1, M S Carneiro-Ramos1

  • 1Laboratório de Imunologia Cardiovascular, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, SP, Brasil.

Insights

Coronavirus disease (COVID-19) is linked to heart and kidney damage, worsening patient outcomes. Understanding the cardiorenal syndrome in COVID-19 is crucial for better disease management and prognosis.

Area of Science:

  • Cardiology
  • Nephrology
  • Infectious Diseases

Background:

  • Coronavirus disease (COVID-19) is associated with multi-organ dysfunction.
  • Cardiac and renal involvement are common in severe COVID-19, indicating a poor prognosis.
  • Systemic inflammation in COVID-19 can damage vital organs, including the heart, kidneys, and blood vessels.

Purpose of the Study:

  • To explore the relationship between COVID-19, cardiac abnormalities, and renal dysfunction.
  • To investigate the impact of cardiorenal syndrome on COVID-19 prognosis.
  • To highlight the importance of understanding cardiorenal interactions in SARS-CoV-2 infection.

Main Methods:

  • Review of case reports of COVID-19 patients with cardiac and renal abnormalities.
  • Analysis of the correlation between organ dysfunction and disease severity.
  • Exploration of the cardiorenal syndrome in the context of COVID-19.

Main Results:

  • COVID-19 patients with heart and kidney abnormalities showed a worse prognosis.
  • The presence of cardiorenal syndrome was linked to increased disease severity.
  • Case reports illustrate the detrimental effects of combined cardiac and renal compromise.

Conclusions:

  • Cardiac and renal involvement are significant indicators of severe COVID-19.
  • The cardiorenal syndrome plays a critical role in the prognosis of COVID-19 patients.
  • Further research into the interplay between cardiac and renal systems during SARS-CoV-2 infection is warranted.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
542
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
517
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
175
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
133
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
870
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82